Minnesota 2025-2026 Regular Session

Minnesota Senate Bill SF4486

Introduced
3/16/26  
Introduced
3/17/26  
Refer
3/16/26  

Caption

Pharmacists authorization to initiate, prescribe, administer, and dispense certain drugs for the treatment of opioid use disorder

Impact

The proposed legislation is poised to modify existing statutes to expand the legal authority of pharmacists. By enabling them to prescribe treatments for opioid use disorder, the bill not only addresses a pressing public health need but also seeks to alleviate some of the burdens on traditional healthcare providers. Consequently, this could lead to more timely access to care for individuals facing addiction issues, potentially improving health outcomes and reducing healthcare costs associated with untreated addiction. The bill seeks to align pharmacist practices with modern approaches to substance use disorder treatment, thereby integrating them more closely into the healthcare delivery system.

Summary

S.F. No. 4486 is a significant legislative measure aimed at enhancing the role of pharmacists in the treatment of opioid use disorder. The bill authorizes licensed pharmacists to initiate, prescribe, administer, and dispense certain drugs specifically for this purpose. This move addresses the growing opioid crisis by allowing pharmacists, as accessible healthcare providers, to take a more active role in managing and treating patients suffering from addiction. The bill outlines the specific conditions under which pharmacists can perform these functions, which includes completing necessary training and obtaining requisite federal registrations to prescribe controlled substances.

Contention

Despite the potential benefits, the bill has raised concerns among various stakeholders. Critics argue about the qualifications and training of pharmacists to handle complex addiction treatment, suggesting that such responsibilities should remain primarily with medical doctors and addiction specialists. The debate highlights the tension between expanding healthcare access and ensuring the highest standard of care, particularly given the challenges associated with opioid prescribing. Proponents counter that with appropriate training, pharmacists can effectively manage treatment plans and provide essential support to patients, thereby improving overall service delivery in a critical area of public health.

Companion Bills

MN HF4493

Similar To Pharmacists authorized to initiate, prescribe, administer, and dispense drugs for the treatment of opioid use disorder; and grounds for disciplinary action for pharmacists and pharmacist interns modified.

Previously Filed As

MN HF4493

Pharmacists authorized to initiate, prescribe, administer, and dispense drugs for the treatment of opioid use disorder; and grounds for disciplinary action for pharmacists and pharmacist interns modified.

MN SB562

State Board of Pharmacy - Prescriber-Pharmacist Agreements - Treatment of Opioid Use Disorders

MN HB855

Relating to promoting, prescribing, administering, or dispensing prescription drugs for off-label use.

MN HF2205

A bill for an act relating to the prescribing, ordering, dispensing, and administering authority of pharmacists and practitioners.

MN H4014

Authorizing pharmacists to provide opioid use disorder treatment

MN SF117

A bill for an act relating to the prescribing, ordering, dispensing, and administering authority of pharmacists and practitioners.(See SF 313.)

MN SF313

A bill for an act relating to the prescribing, ordering, dispensing, and administering authority of pharmacists and practitioners.(Formerly SF 117.)

MN SF3822

Use of prior authorization and step therapy prohibition for drugs used in the treatment of opioid use disorder under medical assistance

MN HF3444

Use of prior authorization and step therapy for drugs used in the treatment of opioid use disorder under medical assistance prohibited.

MN S1635

Authorizing pharmacists to provide opioid use disorder treatment

Similar Bills

MN HF4493

Pharmacists authorized to initiate, prescribe, administer, and dispense drugs for the treatment of opioid use disorder; and grounds for disciplinary action for pharmacists and pharmacist interns modified.

CA AB968

An act to amend Sections 733, 2242.

CA AB50

Pharmacists: furnishing contraceptives.

CA AB2565

Medi-Cal: pharmacist services: reporting.

CA AB1503

Pharmacy.

CA AB1366

Reimbursement for pharmacist services.

CA AB2571

Reimbursement for pharmacist services.

MN SF5234

Pharmacy technicians to pharmacists ratio modifications